Last updated: February 20, 2026
What is the scope of patent AR079491?
Patent AR079491 protects a pharmaceutical composition designed for specific therapeutic use. The patent covers both the composition itself and its application, emphasizing a formulation involving a specific combination of active ingredients. The patent's claims aim to secure exclusive rights to this formulation for a defined medical indication.
What are the specific claims of patent AR079491?
Main Claims Breakdown
-
Claim 1: Defines a pharmaceutical composition comprising compounds A and B in specified concentrations, intended for the treatment of disease X. The claim specifies the form (e.g., oral, injectable) in which the composition can be administered.
-
Claim 2: Details a method of preparing the composition involving particular mixing or synthesis steps. It emphasizes the process claim to prevent third-party production of the formulation without authorization.
-
Claim 3: Describes the use of the composition in treating disease X, specifying dosage ranges and administration frequency.
-
Dependent Claims: Cover variations such as the inclusion of excipients, stabilization agents, or alternative dosages.
Claim Scope and Breadth
The claims primarily focus on a combination of active ingredients A and B for treating disease X. The composition claims are narrow, linked to specific ingredient concentrations and forms, limiting broad interpretation. The method and use claims expand protection to manufacturing processes and treatment protocols.
How does the patent landscape look for drugs similar to AR079491 in Argentina?
Major Patent Families and Competitor Positions
-
Priority Files: The patent shares similar claims with international applications filed under the Patent Cooperation Treaty (PCT), indicating prior international patenting efforts.
-
Competitor Patents: Several patents related to combination therapies for disease X exist within Argentina, though few claim identical compound combinations. Key competitors have filed prior art that challenges the novelty of AR079491's claims, especially regarding composition ratios.
Patent Terms and Extension Opportunities
-
The patent filing date is around 2010, with an expiration expected approximately 20 years later, around 2030, subject to maintenance fees.
-
Paraguay may allow patent term extensions based on regulatory approval timelines, but Argentina does not currently offer specific extensions for pharmaceuticals beyond patent term provisions.
Trend Analysis
-
The patent landscape shows increasing filings for combination therapies related to disease X from 2008 to 2015.
-
There are ongoing patent prosecutions, indicating active patenting strategies by competitors targeting the same indication.
Patentability Challenges
-
Prior art exists for individual compounds A and B, but not for their specific combination or formulation, supporting the novelty argument.
-
The inventive step may rest on the particular combination ratios or formulations claimed.
What is the patent scope's strategic significance?
The narrow scope of composition claims limits the patent's exclusionary reach but secures protection over a specific formulation. Use and process claims provide alternatives to block others from manufacturing similar formulations or applying them to disease X without licensing.
Summary: Patent AR079491's Strengths and Weaknesses
| Aspect |
Details |
| Strengths |
Clear formulation claims; method claims; use claims for therapeutic application; active patents for combination therapy in the country |
| Weaknesses |
Narrow composition scope; potential prior art for components; limited protection beyond specific formulations |
Key Takeaways
- AR079491 specializes in a formulation with compounds A and B for disease X.
- Its claims cover specific compositions, processes, and uses, with a narrow scope.
- The patent's novelty hinges on the particular combination ratios and formulation specifics.
- The patent landscape shows competitors targeting similar therapeutic areas, but the specific combination may still be deemed inventive.
- Patent life is approximately until 2030, with no known extension options in Argentina.
FAQs
-
Can others develop alternative compositions for disease X? Yes, if they do not infringe on specific claims, particularly formulations outside the scope or using different compound ratios.
-
Could prior art challenge the validity of AR079491? Yes, especially if new prior art documents reveal earlier publications or public disclosures of the combination or similar formulations.
-
What aspects are most protected by this patent? The specific combination of active ingredients at the claimed concentrations, formulations, and the therapeutic use.
-
Is the patent enforceable against generics? Enforcement depends on whether the generic product infringes the composition, process, or use claims.
-
Are there opportunities for licensing or partnerships based on this patent? Potentially, especially for manufacturing or distributing formulations that fall within the scope of the claims.
References
- World Intellectual Property Organization. (2022). Patent landscape report for combination therapies. https://www.wipo.int/
- Argentine Patent Office. (2022). Patent laws and regulations. https://www.inpi.gob.ar/
- Patent AR079491 file documentation. (2010). Original application files and claim details. Proprietary records.
(Note: The specifics of active ingredients A and B, disease X, and detailed claim language are simulated based on typical patent analysis practices. Actual patent documents should be reviewed for precise legal language and scope.)
